Analyst Reports
2 May 2024
SBI China Capital - Resilient demand for lens exchange surgeries across four regions and intensive M&A strategy accelerate expansion, maintain the rating of “Buy” and the TP remains at HKD 6.92/share
11 September 2023
SBI China Capital – Euroeyes A Robust Revival in the PRC Steered by the Surge in Presbyopia Correction and Strategic Acquisition of Clinics in Germany
6 September 2023
CICC – EuroEyes: Domestic Business Recovers Rapidly; Overseas Expansion Continues
27 March 2022
Jefferies – EuroEyes: 2021 Sales/ EPS +34%/ +132%YOY; London Acquisition a Big Step to Global Expansion
31 May 2021
Jefferies – EuroEyes: 1Q21 Surgery Volume +52% YOY – All Organic and a Record High; Reiterate Buy
